Flourish Research represents one of the industry’s most progressive and diversified clinical trial companies with robust capabilities in the therapeutic areas of cardiology/metabolic disorders/renal, CNS, pulmonology, and vaccines.
Our sites conduct studies spanning Phases I-IV and covering more than 48 inpatient beds. They have been awarded for excellence in participant recruitment and recognized in the industry for retention, and with our centralized operations, Flourish Research provides a best-in-class experience for patients and sponsors, and CROs, while achieving operational efficiency across key departments.
Jose Alvarez Joins Flourish Research as Chief Operating Officer June 30, 2023 10:55am
Flourish Research, a leading clinical trial company, is pleased to announce the addition of Jose Alvarez as Chief Operating Officer, overseeing the company’s business operation while supporting Flourish’s vision of continued growth and advancement. Read the full release
The post Jose Alvarez Joins Flourish Research as Chief Operating Officer appeared first on Flourish Research.
View this post
Flourish Research Expands with Two New Acquisitions June 2, 2023 11:00am
Flourish Research announces the acquisition of two companies, AMC Research in Charlotte, North Carolina, and Central Research Associates (CRA) in Birmingham, Alabama. AMC is a therapeutically focused Alzheimer’s Disease research site and CRA is a multi-therapeutic site. Both acquisitions complement Flourish’s strategy of acquiring and integrating best-in-class sites. Read the Full Release
The post Flourish Research Expands with Two New Acquisitions appeared first on Flourish Research.
View this post
Flourish Research Joins SCRS as Global Impact Partner May 9, 2023 4:36pm
As part of this partnership, Flourish Research will align with more than 50 other Global Impact Partners comprised of site networks, sponsors, CROs, and solution providers dedicated to establishing collaborative solutions that improve clinical research processes and ensure site sustainability. Read more
The post Flourish Research Joins SCRS as Global Impact Partner appeared first on Flourish Research.
View this post
Flourish Expands with Suncoast Research Group acquisition December 29, 2022 10:07am
Flourish Research announces the acquisition of Suncoast Research Group, adding to the rapidly expanding Flourish enterprise. Suncoast, which is in the Little Havana community of Miami, FL is a large, multi-therapeutic site aligned with Flourish’s core therapeutic areas of Cardiology/Metabolic, CNS and Vaccines. Read the full release.
The post Flourish Expands with Suncoast Research Group acquisition appeared first on Flourish Research.
View this post
Chris Duignan Joins Flourish Research as Chief Financial Officer November 8, 2022 3:15pm
Chris Duignan, who has been named Chief Financial Officer of Flourish Research, will build the financial infrastructure, lead financial operations, and integrate the acquisitions of the rapidly growing organization. Read the full release.
The post Chris Duignan Joins Flourish Research as Chief Financial Officer appeared first on Flourish Research.
View this post
Flourish Expands with Keystone Clinical Acquisition October 20, 2022 2:51pm
Flourish Research announces the acquisition of Keystone Clinical Studies, adding to the rapidly expanding Flourish enterprise. Keystone, which is in the greater Philadelphia area, is a leader in Alzheimer’s Disease and other CNS research and the addition of the site expands Flourish’s reach in these core areas of research. Read the full release.
The post Flourish Expands with Keystone Clinical Acquisition appeared first on Flourish Research.
View this post
